Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy

NCT00786383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: IMC-1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B

Sponsor

Eli Lilly and Company